Begin main content

Reports

We found 4564 result(s)

Health Technology Update — Issue 10

Published on: May 15, 2009
Result type: Reports
Product Line: Health Technology Update

Welcome to the tenth issue of Health Technology Update. This first newsletter of 2009 brings you more information about technologies that could significantly impact the health of patients and lead to high quality, efficient, and sustainable health care in Canada. Our feature article highlights assisted reproductive technologies, specifically in ...

Files

    Health Technology Update — Issue 11

    Published on: August 11, 2009
    Result type: Reports
    Product Line: Health Technology Update

    Welcome to the eleventh issue of Health Technology Update. This second newsletter of 2009 brings you information on a variety of medical technologies. The issue’s feature article addresses the current global crisis in isotope production in medical imaging. New and emerging technologies and practices are currently being identified that may play a...

    Files

      Citations and Other Key Publications

      Published on: October 25, 2011
      Result type: Reports

      Media Contact Janet Crain
      Manager, Knowledge Mobilization
      Canadian Agency for Drugs and Technologies in Health
      Tel: (613) 226-2553, ext. 1487
      Email: janetc@cadth.ca Read What Others Have Said Utilization Patters and Reimbursement Options for Diabetes Test Strips in British Columbia (UBC Centre for Health Services and Poli...

      Guide to Starting and Adjusting Insulin for Type 2 Diabetes

      Published on: July 16, 2012
      Result type: Reports

      Adapted from Guide to Starting and Adjusting Insulin for Type 2 Diabetes, ©2008 International Diabetes Center, Minneapolis, MN. All rights reserved. Many people with type 2 diabetes need insulin therapy. A variety of regimens are available. Here are some tips when discussing insulin therapy:1 Discuss insulin early to change negative perceptions ...

      Files

        Tools

        Published on: August 10, 2016
        Result type: Reports

        The Canadian Agency for Drugs and Technologies in Health (CADTH) developed the following tools to help transition our recommendations from paper into practice. To make these tools relevant to different audiences, CADTH can tailor specific tools to individual needs and settings. Contact us if you would like our assistance in tailoring any of thes...

        CADTH MRI Expert Advisory Panel

        Published on: May 3, 2011
        Result type: Reports

        Chair Dr. Jean Gray CERC/CEDAC Members Dr. Scott Klarenbach Dr. James Silvius Dr. Lindsay Nicolle Public Member Mr. Harlon Davey Clinical Expert Members Dr. Darren Ferguson Dr. Martin Charron Dr. Alexander Dick Dr. Matthias Schmidt Dr. Andre le Roux Chair Jean Gray, CM, MD, FRCPC, LLD, DSc Dr. Jean Gray is currently Professor Emeritus, Medical E...

        KM and Impact: SMBG in the Real World

        Published on: August 10, 2011
        Result type: Reports

        Educating Patients Educating Health Care Providers Other Efforts to Educate and Exchange Knowledge Educating Patients As one of the first health care co-operatives in Saskatchewan, the Saskatoon Community Clinic is focused on providing care for the whole person, and on encouraging and helping individuals to play a role in their own health care. ...

        COMPUS Expert Review Committee

        Published on: September 9, 2011
        Result type: Reports

        Chair Dr. Lisa Dolovich   Participating CERC Members Dr. Scott Klarenbach Dr. James Silvius Dr. Michael Allen Dr. Michael Evans Dr. Adil Virani   Public Members Ms. Cathy MacNutt Mr. Panos Petrides  Specialist Members Dr. Marc Carrier Dr. Agnes Y. Lee Dr. Jafna Cox Dr. Mario Talajic Dr. Anne Holbrook Dr. Leslie Zypchen (backup for Dr. A...

        The cost-effectiveness of G-CSF for prophylaxis of febrile neutropenia after standard dose chemotherapy

        Published on: January 1, 1997
        Result type: Reports

        Tags

        Neutropenia, Granulocyte Colony-Stimulating Factor, Drug Therapy, Antineoplastic Agents, Cost-Benefit Analysis, G-CSF, Chemotherapy, Cancer, Antineoplastic Agents, Chemotherapy, Neutropenia, Granulocyte Colony-Stimulating Factor, G-CSF, Cancer, Cancer drugs, Economic, Neutropénie, Facteur stimulant colonie granulocyte, Chimiothérapie, Antinéoplasiques, Analyse coût bénéfice, Pluripoietine, Anticancéreux, Les coûts

        Pharmacoeconomic evaluation in schizophrenia: clozapine in treatment-resistant schizophrenia and risperidone in chronic schizophrenia.

        Published on: July 1, 1997
        Result type: Reports

        Cite as: Glennie JL. Pharmacoeconomic evaluations of clozapine in treatment-resistant schizophrenia and risperidone in chronic schizophrenia. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Background Schizophrenia is a prevalent psychiatric disorder with extremely high direct, indirect, and intangible costs...

        Tags

        Schizophrenia, Clozapine, Risperidone, Antipsychotic Agents, Drug Therapy, Cost-Benefit Analysis, Clozapine, Schizophrenia, Antipsychotic Agents, Risperidone, Schizophrenia, schizophrénie, Atypical antipsychotics, Economic, Neuroleptiques, Chimiothérapie, Analyse coût bénéfice, Neuroleptiques non traditionnels, Évaluation économique